Immunotherapeutic approaches for hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a cancer with a high mortality rate due to the fact that the diagnosis usually occurs at anadvanced stage. Even in case of curative surgical treatment, recurrence is common. Sorafenib and regorafenib are the only therapeutic agents that have been demonstrated to be...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Longo, Vito, Gnoni, Antonio, Gardini, Andrea Casadei, Pisconti, Salvatore, Licchetta, Antonella, Scartozzi, Mario, Memeo, Riccardo, Palmieri, Vincenzo Ostilio, Aprile, Giuseppe, Santini, Daniele, Nardulli, Patrizia, Silvestris, Nicola, Brunetti, Oronzo
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2017
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5464921/
https://ncbi.nlm.nih.gov/pubmed/28420805
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15406
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky